Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹68.25
0.04 (0.06%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹144 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
10.1
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹46.1+48.0%
52W High₹105.9-35.6%
Current Price
₹68.25
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹54.60
Upper Circuit₹81.90
Reference Price
₹68.25
Investment Checklist
Double Top on 1W (BREAKOUT CONFIRMED) — target ₹57.25
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹58.15
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
45%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition
EMA20
68.47
EMA50
68.2
EMA200
75.45
Price Action
CONSOLIDATION
NEUTRAL
Higher Highs5
Higher Lows3
Lower Highs3
Lower Lows6
Support & Resistance Levels
Resistance (Above)
₹70.69
₹72.21
₹73.69
₹75.02
₹76.18
Support (Below)
₹66.24
₹64.55
₹63.75
₹62.44
₹61.00
Volume Analysis
TrendDECREASING
Change-59.00%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹67.57
3% Risk₹66.20
5% Risk₹64.84
7% Risk (Custom)
₹63.47Technical Levels
1x ATR (Volatility)₹65.94
2x ATR (Swing)₹63.63
3x ATR (Trend)₹61.32
Immediate Support₹66.24
Moving Averages
EMA 50 (Trend)₹68.20
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹26.2 Cr | ₹39.1 Cr | ₹19.1 Cr | ₹26.3 Cr |
| Net Profit | ₹8.9 Cr | ₹-2.2 Cr | ₹11.8 Cr | ₹11,25,000 |
| EPS | ₹4.23 | — | ₹5.59 | ₹0.05 |
| Operating Profit | ₹9.5 Cr | ₹2.4 Cr | ₹12.4 Cr | ₹81,83,000 |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Alpa Laboratories Limited | ₹68.25 | -0.06% | 10.1 | ₹144 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 20 Sept 2024 | Annual General Meeting | AGM |
| 21 Sept 2023 | Annual General Meeting | AGM |
| 20 Sept 2022 | Annual General Meeting | AGM |
| 20 Sept 2021 | Annual General Meeting | AGM |
| 18 Sept 2020 | Annual General Meeting | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ALPA
View All
negative
ET Markets - Industry 115d ago
Pilots' body advisory: Ensure that airlines assess risk before planning flights in conflict-hit areas
ALPA India has put forth an important notice directed at pilots, emphasizing the necessity of conducting risk evaluations prior to approaching any conflict zones. As tensions rise in West Asia, it’s vital for pilots to recognize the rapidly shifting landscape of risks.
ALPAVITALChemicalsHealthcare